Related Experiment Video
Updated: May 24, 2026

Transcutaneous Microcirculatory Imaging in Preterm Neonates
Published on: December 31, 2015
Feasibility study of early blood pressure management in extremely preterm infants
Beau J Batton1, Lei Li, Nancy S Newman
1Department of Pediatrics, Rainbow Babies & Children's Hospital, Case Western Reserve University, Cleveland, OH, USA. bbatton@siumed.edu
Insights
This pilot study found that a randomized controlled trial for blood pressure management in extremely preterm infants was not feasible due to low enrollment and consent rates. Future trials may need waivers of consent and alternative medications.
Area of Science:
- Neonatal medicine
- Clinical trial methodology
Background:
- Extremely preterm infants often experience low blood pressure (BP).
- Effective BP management is crucial for neonatal outcomes.
- Previous research on BP management in this population is limited.
Purpose of the Study:
- To determine the feasibility of conducting a randomized placebo-controlled trial (RCT) for blood pressure management in extremely preterm infants.
Main Methods:
- A prospective pilot randomized controlled trial (RCT) was conducted.
- Infants born between 23-0/7 and 26-6/7 weeks gestation with low BP were enrolled.
- Infants received either dopamine or placebo infusion, and hydrocortisone or placebo medication.
Main Results:
- Only 3% of screened infants were enrolled, with 17% of eligible infants enrolled.
- Low eligibility and consent rates were major barriers.
- Early indomethacin use excluded many infants due to potential drug interactions.
Conclusions:
- The pilot RCT was not feasible due to low enrollment and consent.
- Future RCTs may require a waiver of consent for emergency care research.
- The risk of intestinal perforation with combined hydrocortisone and indomethacin may necessitate using only inotropic agents.
Objective:
To assess the feasibility of a randomized placebo controlled trial (RCT) of blood pressure (BP) management for extremely preterm infants.
Study Design:
This was a prospective pilot RCT of infants 23-0/7 to 26-6/7 weeks gestation who had protocol-defined low BP in the first 24 postnatal hours. Enrolled infants were administered a study infusion (dopamine or placebo) and a study syringe medication (hydrocortisone or placebo).
Results:
Of the 366 infants screened, 119 (33%) had low BP, 58 (16%) met all entry criteria, and 10 (3%) were enrolled. A total of 161 infants (44%) were ineligible because they received early indomethacin. Only 17% of eligible infants were enrolled. Problems with consent included insufficient time, parent unavailability, and physician unwillingness to enroll critically ill infants. Two infants were withdrawn from the study because of the potential risk of intestinal perforation with simultaneous administration of hydrocortisone and indomethacin.
Conclusions:
This pilot RCT was not feasible because of low eligibility and consent rates. An RCT of BP management for extremely preterm infants may require a waiver of consent for research in emergency care. The frequent use of early indomethacin and the associated risk of intestinal perforation when used with hydrocortisone may limit future investigations to only inotropic medications.
Related Concept Videos
Pre-Procedural Guidelines for Assessing Blood Pressure
Errors occurring during blood pressure monitoring
Several factors...
Hypertension V: Nursing Management
Special considerations while measuring blood pressure
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Measurement of Blood Pressure
Factors affecting Blood pressure
Physiological Factors: